March 3, 2026Dementia and Neurocognitive Disorders0 citationsOpen Access

The Clinical Utility of the Cognitive Impairment Screening Test (CIST)

HHHyeseon HanSamsung Medical Center SLSoyeon LimSamsung Medical Center SKSuah KimSamsung Medical Center

Key Points

Cognitive impairment screening tests are essential for early detection, demonstrating significant validity and discriminative power.
The CIST effectively identifies amyloid positivity among non-demented individuals, highlighting its relevance in clinical settings.
Observational analysis revealed the CIST's strong potential for detecting cognitive impairment across various demographics.
This tool may enable more precise early interventions for cognitive issues, improving long-term outcomes in affected individuals.

Abstract

The CIST demonstrated strong validity and discriminatory ability for detecting cognitive impairment. It also showed acceptable discrimination for amyloid positivity in non-demented participants, supporting its utility as a screening tool in both clinical and community settings.

AIに質問

Bookmark

View Full Paper